Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-007933
Filing Date
2010-02-09
Accepted
2010-02-09 17:24:57
Documents
1
Period of Report
2010-02-07

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c95888_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c95888_4x0.xml 4 3879
  Complete submission text file 0001209191-10-007933.txt   5883
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 263 CYPRESS ST. BROOKLINE MA 02445
Business Address
Lauterbach Sandra Leigh (Reporting) CIK: 0001479218 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 10585349